Prognostic Impact Of Baseline Immunologic Profile In Aggressive B-cell Non-Hodgkin’s Lymphomas

Not requested

Saved in:

Bibliographic Details
Main Author:	Safaa M. Ramadan
Format:	Article
Language:	English
Published:	PAGEPress Publications 2021-02-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Immunologlobulin IGG Prognosis Aggressive B-cell Non-Hodgkin’s Lymphoma lymphocyte-monocyte ratio
Online Access:	https://www.mjhid.org/index.php/mjhid/article/view/4469
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
by: Annarosa Cuccaro, et al.
Published: (2014-07-01)

PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01)

Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Special Type of (Follicular) B-Cell Lymphoma?
by: Antonino Carbone, et al.
Published: (2024-11-01)

Impact of Comorbidities on Prognosis and Treatment Outcomes in Elderly Patients with Hodgkin Lymphoma
by: Dávid Tóthfalusi, et al.
Published: (2025-01-01)

HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
by: Antoine Thyss, et al.
Published: (2014-07-01)

THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
by: Umberto Ricardi, et al.
Published: (2014-05-01)

A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery
by: Matteo D'Addona, et al.
Published: (2023-10-01)

Interfollicular Hodgkin’s lymphoma: A diagnostic challenge for pathologists
by: Maneesh K. Vijay, et al.
Published: (2023-03-01)

Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma
by: Valentina Giudice, et al.
Published: (2022-04-01)

COEXISTENCE OF RENAL CELL CARCINOMA AND HODGKIN' S LYMPHOMA
by: Gokhan Sargin, et al.
Published: (2014-08-01)

Use of rituximab in mature, high-grade and advanced-stage pediatric B-lineage non-Hodgkin lymphomas: a systematic review, meta-analysis and the Brazilian reality
by: Alejandra Adriana Cardoso de Castro, et al.
Published: (2025-01-01)

Evaluation of C-reactive protein and its prognostic relationship in patients with Hodgkin's Lymphoma
by: Elizete Negreiros, et al.
Published: (2024-12-01)

EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
by: Massimiliano Salati, et al.
Published: (2014-06-01)

Prognostic factors and predictive models for primary pulmonary diffuse large B-cell lymphoma: a population-based analysis
by: Xiaoyu He, et al.
Published: (2024-12-01)

Hodgkin Lymphoma Development After the Diagnosis of Idiopathic
by: Oktay Bilgir, et al.
Published: (2014-08-01)

Primary uterine non-Hodgkin’s lymphoma:a rare case report and review of the literature
by: Jing Wu, et al.
Published: (2024-12-01)

Hodgkin lymphoma novel management; A 20-year retrospective study
by: Farid Ghazizadeh, et al.
Published: (2024-06-01)

Upregulation of CD19 by low‐dose chidamide promotes CAR T cells functionality in B-cell non-Hodgkin lymphoma
by: Ying Ni, et al.
Published: (2025-01-01)

AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
by: Giuseppe Visani, et al.
Published: (2012-11-01)

Chemotherapy-colchicine interaction in a child with Familial Mediterranean Fever and Hodgkin Lymphoma
by: Karin Petra Sabine Langenberg-Ververgaert, et al.
Published: (2018-03-01)

HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
by: Anna Maria Testi, et al.
Published: (2024-06-01)

Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
by: Dan Zou, et al.
Published: (2024-11-01)

PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW
by: Maria Luisa Moleti, et al.
Published: (2024-10-01)

The prognostic utility of the ratio of lymphocyte to monocyte in patients with metastatic colorectal cancer: a systematic review and meta-analysis
by: Pingping Mei, et al.
Published: (2025-02-01)

Primary pulmonary Hodgkin Lymphoma simulating a mediastinal tumour: an uncommon occurrence.
by: Stefano Fratoni, et al.
Published: (2013-02-01)

Autoimmune Diseases and Risk of Non‐Hodgkin Lymphoma: A Mendelian Randomisation Study
by: Xiaoting Shi, et al.
Published: (2024-11-01)

B-cell non-Hodgkin's lymphoma in the patient with chronic hepatitis C and mixed cryoglobulinemia
by: V. S. Adonyeva, et al.
Published: (2015-03-01)

TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
by: Agustin Avilès, et al.
Published: (2018-01-01)

A case report of chondroblastic osteosarcoma following treatment for Hodgkin lymphoma
by: Tenille A. Abrahams, et al.
Published: (2024-11-01)

Hodgkin Lymphoma Presenting as Pel–Ebstein Fever: A Case Report
by: Ujjawal Kumar Shriwastav, et al.
Published: (2024-11-01)

A Rare Case of Primary Vulvar Diffuse Large B‐Cell Lymphoma: A Case Report
by: M. Singh, et al.
Published: (2024-12-01)

The role of CPET in patients with reduced physical capacity and Hodgkin's disease at clinical remission
by: V. Dimitrova, et al.
Published: (2024-12-01)

The prognostic impact of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in patients with advanced colorectal cancer treated with first-line chemotherapy
by: Magdalena Krakowska, et al.
Published: (2018-09-01)

Immunohistochemical study of non-Hodgkin lymphoma patients in Basrah (Single center experience)
by: Haider Abdul Hassan ALI, et al.
Published: (2024-06-01)

Bayesian Parametric Survival Analysis of Patients With Non-Hodgkin’s Lymphoma in Yazd, Iran, During 2009-2019
by: Hossein Fallahzadeh, et al.
Published: (2024-06-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
by: Ercole Brusamolino, et al.
Published: (2014-08-01)

Non-Hodgkin's lymphoma in the practice of the family doctor (clinical observation).
by: I. V. Vasylevska
Published: (2018-05-01)

Prognostic value of the platelet, neutrophil, monocyte, basophil, and eosinophil to lymphocyte ratios in patients with severe community-acquired pneumonia (SCAP)
by: Xiao-Jiao Cui, et al.
Published: (2024-12-01)

Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysis
by: Fanqiao Meng, et al.
Published: (2025-01-01)

Epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019
by: Wen-Tao WU, et al.
Published: (2021-12-01)